Source: Eur Respir J 2009; 33: 1520
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Enoz M., Inancli H. M.. CPAP and measures of cardiovascular risks in patients with OSAS. Eur Respir J 2009; 33: 1520

Member's Comments

No comment yet.

Related content which might interest you: Can CPAP reduce adverse cardiovascular and metabolic effects of OSAS? Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS) Year: 2007 Nocturnal BP pattern and cardiovascular risk in a group of patients with moderate-severe OSAS. Evaluation of the effect of CPAP treatment Source: Eur Respir J 2007; 30: Suppl. 51, 335s Year: 2007 Co-morbidities and cardiovascular medications are the best predictors of mortality in patients with obesity-associated hypoventilation treated with long-term non-invasive ventilation Source: Annual Congress 2012 - Current trends in home mechanical ventilation Year: 2012 Predictors of compliance with CPAP in patients with OSA and metabolic syndrome Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009 CPAP setting prediction in OSAS patients Source: Annual Congress 2011 - Physiology and diagnostic technology in obstructive sleep apnoea Year: 2011 Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002 Cardiovascular risk markers in patients with OSA. Effects of CPAP treatment Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012 Effect of compliance to continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 320s Year: 2007 Weight and metabolic effects of CPAP in OSA patients with obesity Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise Year: 2010 The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 The effect of CPAP in asthma patients with SAHS Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes Year: 2021 Long-term nCPAP compliance in patients with OSAS with initial in-hospital adjustment of nCPAP Source: Eur Respir J 2002; 20: Suppl. 38, 102s Year: 2002 The reversibility of hypoxemia in OSA patients is related to CPAP therapy Source: Eur Respir J 2005; 26: Suppl. 49, 112s Year: 2005 Effects of CPAP treatment in UARS patients comparing to OSAS patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 CPAP therapy in OSA patients: The effects on healthcare use and medical costs related to cardio- and cerebrovascular diseases Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea: effect of CPAP treatment Source: Eur Respir J 2012; 39: 906-912 Year: 2012 Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006 Predictive factors for stopping use of continuous positive airway pressure (CPAP): an observational cohort of 6938 treated obstructive sleep apnea syndrome (OSAS) patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients? Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006